EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Diagnostic challenges of diabetic kidney disease

Marijana Vučić Lovrenčić, Sandra Božičević, Lea Smirčić Duvnjak

Biochemia medica · 15.10.2023 · 33 (3) · 227-241

DOI: 10.11613/bm.2023.030501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemia medica, online erschienen am 13.10.2023. Verfasst von Marijana Vučić Lovrenčić und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of clinical chemistry and laboratory medicine, University hospital Merkur, Zagreb, Croatia. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is one of the most common microvascular complications of both type 1 and type 2 diabetes and the most common cause of the end-stage renal disease (ESRD). It has been evidenced that targeted interventions at an early stage of DKD can efficiently prevent or delay the progression of kidney failure and improve patient outcomes. Therefore, regular screening for DKD has become one of the fundamental principles of diabetes care. Long-established biomarkers such as serum-creatinine-based estimates of glomerular filtration rate and albuminuria are currently the cornerstone of diagnosis and risk stratification in routine clinical practice. However, their immanent biological limitations and analytical variations may influence the clinical interpretation of the results. Recently proposed new predictive equations without the variable of race, together with the evidence on better accuracy of combined serum creatinine and cystatin C equations, and both race- and sex-free cystatin C-based equation, have enabled an improvement in the detection of DKD, but also require the harmonization of the recommended laboratory tests, wider availability of cystatin C testing and specific approach in various populations. Considering the complex pathophysiology of DKD, particularly in type 2 diabetes, a panel of biomarkers is needed to classify patients in terms of the rate of disease progression and/or response to specific interventions. With a personalized approach to diagnosis and treatment, in the future, it will be possible to respond to DKD better and enable improved outcomes for numerous patients worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes Mellitus, Type 2HumansCystatin CGlomerular Filtration RateBiomarkers

Stichwörter der Autor:innen

albuminuriabiomarkersdiabetic nephropathydiagnostic testsglomerular filtration rate

Substanzen

Cystatin CBiomarkers

Autor:innen und Institutionen

  • Department of clinical chemistry and laboratory medicine, University hospital Merkur, Zagreb, Croatia.
  • Vuk Vrhovac University clinic for diabetes, endocrinology and metabolic diseases, University hospital Merkur, Zagreb, Croatia.
  • School of medicine, University of Zagreb, Zagreb, Croatia.

Zitieren

APA

Vučić Lovrenčić, M., Božičević, S., & Smirčić Duvnjak, L. (2023). Diagnostic challenges of diabetic kidney disease. Biochemia medica, 33(3), 227-241. https://doi.org/10.11613/bm.2023.030501

Vancouver

Vučić Lovrenčić M, Božičević S, Smirčić Duvnjak L. Diagnostic challenges of diabetic kidney disease. Biochemia medica. 2023;33(3):227-241. doi:10.11613/bm.2023.030501

BibTeX
@article{VuiLovreni2023,
  author = {Vučić Lovrenčić, Marijana and Božičević, Sandra and Smirčić Duvnjak, Lea},
  title = {Diagnostic challenges of diabetic kidney disease},
  journal = {Biochemia medica},
  year = {2023},
  volume = {33},
  number = {3},
  pages = {227--241},
  doi = {10.11613/bm.2023.030501}
}
Kostenlos starten →